Abstract
Crocus sativus L. (Iridaceae) is a stemless herb produced in Iran, Afghanistan, Turkey, Spain, Greece, and India. It is commonly known as saffron and used since historical times as an important crop of food and nutraceuticals and for its therapeutic importance. The main use of this plant comes from yellow-coloured dried stigmas having a bitter taste and intense aroma. Saffron contains aroma-yielding compounds and volatiles (150) of different chemical natures such as terpenes, terpene alcohol, and their esters. Around 135 bioactive molecules have been isolated including chemical markers (crocin, crocetin, picrocrocin, and safranal) from C. sativus. The picrocrocin and safranal are major contributors for its bitter taste and hay fragrance. Golden herb possesses a variety of therapeutic potentials such as antimicrobial including antiparasitic and antibacterial, antioxidant, hypotensive, hypolipidemic, anxiolytic, antidepressant, anticonvulsant, antinociceptive, anti-inflammatory, diuretic, cytotoxic, etc. In addition, saffron also possesses various health-promoting properties like treating asthma, menstrual cramps, depression, and many more. Many ayurvedic and herbal formulations have been prepared from saffron which includes skincare and health-care products. Saffron is an expensive spice with a price of for 1 kg stigmas around 600–1000$. The high cost and demand of the golden spice encourage the scientific community to made efforts for its large-scale production. Hence, quality insurance of saffron needs to be certified as per ISO/FDA. The overview of the background, phytochemistry, pharmacological activities, substitutes, adulterants, toxicity, and formulations has been discussed along with quality and standardization methods of saffron.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
7.1 Introduction
Crocus sativus L. (Iridaceae) is a stemless high-value medicinal and aromatic plant found in Europe, Asia, and America. The saffron word originated from Safran, a French word that means “yellow” (Evans 1997; Harper 2001; Mozaffarian 1996). Etymologically, Crocus is derived from the Greek word Croci meaning thread and Sativus meaning cultivation (Deo 2003). The plant has different names region-wise, e.g. in Arab it is known as Zahafaran, and in India Saffron [Keshar (Hindi), Kumkuma (Sanskrit), and Kungumapu (Tamil)]. C. sativus in addition to dye, perfume, and medicine has also been considered in culinary since ages (Abrishami 1997). It is the world’s most valuable spice because of short flowering season of fewer than 3 weeks and effortful harvesting and 1 kg of stigmas can cost up to 1000$ (USDA 2009). Saffron has a strong fragrance, bright yellow-orange colour, and bitter taste. For this reason, saffron is often used in the aroma as well as in colour industry (Wani et al. 2011; Saeidnia 2012).
7.2 Origin and History
Saffron has a historical background of use and cultivated since antiquity. It has been cultivated for use as a dye and was the most loved and high-value spice crop of ancient Greeks, Romans, and Egyptians. The evidences for the use of saffron are around from 2400 BC, and more proofs for its use in colouring tunics exist in Spain. The saffron became popular in Mesopotamia with the civilization of Babylonian culture. Ancient scripts talk about utilization as a flavouring agent during the rule of Hammurabi (1800–1700 BC) and are also found in the text of Kashmir (fifth century BC). Iran, India (J&K), and Spain are the highest growers of saffron in the global market. In Persian text, the use of saffron for paper production as well as for the preparation of ink of different shades has been mentioned. Saffron ink was used to write the holy prayers and scripts by the rulers and royal peoples. There is also evidence of saffron use by Sumerians around 5000 years ago which signifies its silver past.
7.3 Morphology
Saffron is a perennial herb with purple-coloured flowers having three stamens and a corm of 2 in. diameter. Each corm produces 5–9 small leaves (Fig. 7.1). The plant propagates through corms by sprinkling the roots at the base and circumference of the corms. The flowering occurs in late winters and spring (Evans 1997). In the first year, the corms did not produce flower buds due to lack of proper nourishment. The flower contains three indistinguishable sepals and petals. From the centre of flowers is located an ovary which ends up in a yellow-coloured style that gives rise to orange-red coloured stigmas, the main source of saffron. Flowers are sterile and hence don’t provide any seeds. Hence, the mode of propagation is through corms, and a single corm produces one to seven flowers (Srivastavan et al. 2010).
7.4 Classification
Kingdom—Plantae | Family—Iridaceae |
Division—Magnoliophyta | Species—sativus |
Class—Liliopsida | Genus—Crocus |
Order—Asparagales |
7.5 Traditional Uses
Saffron has been used in European culinary since ages for colour and flavour and also as important ingredients of Gugelhupf which is a German cake. Additionally, dairy items incorporate it to impart colour and flavour. Romanians used saffron for relieving hangovers. It has excellent antispasmodic properties and is used for pain relief (sixteenth to nineteenth centuries; Schmidt and Betti 2007). It has expectorant, aphrodisiac, sedative, and anxiolytic effects. The Egyptian mentions saffron for kidney and liver problems and in dysentery, measles, gallbladder, and urinary tract infections (Baumann 1960; Grisolia 1974). However, a higher dosage of saffron may act as an abortifacient and also lead to temporary paralysis (Malairajan et al. 2006).
7.5.1 Phytochemistry of C. sativus
It is the most explored and well-known species of the genus Crocus. Crocetin and its esters, safranal and picrocrocin, are the quality control chemical markers of saffron. Major classes of compounds isolated from saffron include diterpenes, triterpenes, tetraterpenes, monoterpenoids, flavonoids and phenolics, carboxylic acids, sterols, nitrogen-containing compounds, and other classes. Detailed descriptions are discussed below.
7.5.1.1 Apocarotenoids and Their Derivative
It is the most characteristic class of phytochemicals that are reported in C. sativus stigmas. Crocetin (1) and its glycosidic esters crocins (2–10) are major water-soluble apocarotenoids, whereas phytoene, zeaxanthin, beta-carotene, and lycopene (11–14) are fat-soluble carotenoids present in saffron (Mykhailenko et al. 2019; García-Rodríguez et al. 2017; Figs. 7.2 and 7.3; Table 7.1). In saffron, the crocin is about 6–16% of dry weight and can further be increased to 30% by its cultivation and processing practices (Hu et al. 2015; Gregory et al. 2005; Kyriakoudi et al. 2012; Liorens et al. 2015). A novel xanthone, mangicrocin (15), has also been reported from C. sativus stigmas (Ordoudi and Tsimidou 2004; Fig. 7.4).
7.5.1.2 Monoterpenoids
Picrocrocin (16) is a major chemical compound of volatile oil responsible for saffron essence, whereas safranal (17) constitutes over 60% of the oil and contributes to its bitter taste (Tarantilis and Polissiou 1997). Maggi and team provided the information that β-isophorone (19), isophorone isomer (20), α-pinene (21), 1,8-cineole (22), and β-ionone (23) are also the main components of essential oil, in addition to 16 and 17 (Maggi et al. 2010; Mykhailenko et al. 2019). (4R)-4-hydroxy-2,6,6-trimethylcyclohex-1-enecarbaldehyde4-O-[β-d-glucopyranosyl (1 → 3)-β-d-glucopyranoside] (24), a safranal glycoside, was reported from the alcoholic extract of saffron (Mykhailenko et al. 2019). Red saffron stigmas contain β-cyclocitral (25) and 4-oxoisophorone (26; Tarantilis and Polissiou 1997), whereas crocusatins (A-L; 27-38) were isolated and reported from stigmas, petals, and pollens (Li and Wu 2002a; Mykhailenko et al. 2019). The main monoterpenoids (16-38) from saffron are depicted in Fig. 7.5 and Table 7.1.
7.5.1.3 Flavonoids
Flavonoids are accumulated in all the tissues of C. sativus. The structure of flavonoids and their derivatives from C. sativus (compounds 39–89) are depicted in Table 7.1 and graphed in Figs. 7.6, 7.7, 7.8, and 7.9. Flavonoids are further classified into different classes and discussed below in detail.
7.5.1.4 Flavone Derivatives
Flavones are the second most abundant class found in saffron. The compounds 39–70 fall under this category and are distributed in various tissues of the plant. The compounds are discussed in Table 7.1 and Fig. 7.6. The chromatographic studies based on mass fragmentation pattern detected the kaempferol (39), kaempferol 3-O-sophoroside-7-O-β-d-glucopyranoside (40), sophoraflavonoid (41), and kaempferol 7-O-β-d-sophoroside (44) in abundance (Mykhailenko et al. 2019) while kaempferol 3,7,4′-tri-O-β- glucopyranoside (43), kaempferol-3-dihexoside (44), astragalin (45; Li et al. 2004; Tung and Shoyama 2013), populin (46; Straubinger et al. 1997; Moraga et al. 2009a, 2009b), 47, 48, 49, and their synthetically prepared derivatives such as 50 and 51 in low levels (Carmona et al. 2007;Vignolini et al. 2008; Montoro et al. 2008; Li et al. 2004). Similarly, quercetin, isorhamnetin, and their derivatives (55–68; Montoro et al. 2008, 2012; Norbeak et al. 2002), myricetin (70; Gismondi et al. 2012) and rhamnetin (78), were also reported in C. sativus stigmas (Fig. 7.6).
7.5.1.5 Flavonone Derivatives
Compounds (71–75) are categorized as flavonone derivatives and distributed in stigmas, petals, stamens, and leaves. The dihydrokaempferol (71; Mykhailenko et al. 2019), dihydrokaempferol 3-O-hexoside (72; Mykhailenko et al. 2019), and taxifolin 7-O-hexoside (73) were isolated, whereas naringenin 7-O-hexoside naringenin (74–75) were detected from stigmas (Mykhailenko et al. 2019; Fig. 7.7).
7.5.1.6 C-Flavone Derivatives
Compounds (76–80) are categorized as C-flavone derivatives and distributed mainly in leaves and tepals. Kaempferol 8-С-glycosides (76-77) were reported only in the leaves, whereas isoorientin (78), vitexin (79), and orientin (80) were noticed in the leaves and petals (Fig. 7.8; Mykhailenko et al. 2019).
7.5.1.7 Anthocyanins
Compounds (81–89) are categorized as anthocyanins and distributed mainly in tepals and petals of violet saffron (Lotfi et al. 2015). Nine anthocyanin derivatives, namely, 3,7-di-O-β-glucoside of delphinidin (81) and petunidin (83), 3,5-di-O-β-glucoside of petunidin (82), 3-O-β-d-glucosides of petunidin (84) and delphinidin (85), petunidin (86), pelargonidin 3-O-β-d-glycopyranoside (87), pelargonidin 3,5-glycosides (88), and 3,5 cyanidin-diglycoside (89) were identified using HPLC (Fig. 7.9; Norbeak et al. 2002).
7.5.1.8 Phenols and Their Derivatives
Stigmas of C. sativus were studied in-depth for its aromatic compounds (90-107). The distribution of these compounds among the different tissues was categorized under this class. The hydroxycinnamic acids, caffeic acid (90), chlorogenic acid (91; Gismondi et al. 2012), ferulic acid (92), p-coumaric acid (93), and sinapic acid (94), were reported in C. sativus. (Fig. 7.10 and Table 7.1). Several isolated and identified hydroxybenzoic acids and carboxylic acid, namely, gallic acid (95; Mykhailenko et al. 2019), protocatechuic acid(96), vanillic acid (97), p-hydroxybenzoic acid (98), 3-hydroxy-4-methoxybenzoic acid (99), syringic acid (100), gentisic acid (101), salicylic acid (102), benzoic acid (103), cinnamic acid (104), protocatechuic acid methyl ester (105), methylparaben (106; Li and Wu 2002a), and (3S),4-dihydroxybutyric acid (107), were reported (Fig. 7.10).
7.5.1.9 Phytosterols
Phytosterols (108–112) were detected in stigma, petals, and corms (Feizy and Reyhani 2016; Fig. 7.11 and Table 7.1).
7.5.1.10 Vitamins
Three vitamins, namely, riboflavin (113; Hashemi and Erim 2016), thiamine (114), and pyridoxal (115; Lim 2014), were detected in stigma.
7.5.1.11 Nitrogen-Containing Compounds
Tribusterine (116), adenosine (117), harman (118), nicotinamide (119), uracil (120), and thymine (121; Fig. 7.12) were detected in stigmas, petals, sprouts, and pollens (b; Li and Wu 2002a).
7.5.1.12 Furan Derivatives
(4R)-4-Hydroxy-dihydrofuran-2-one-O-β-d-glucopyranoside (122), (4S)-4-hydroxy-dihydrofuran-2-one-O-β-d-glucopyranoside (123), and 2-Formyl-5-methoxyfuran (124) were detected in stigmas (Fig. 7.13; Li and Wu 2002a, b).
7.5.1.13 Triterpenoid Saponins
Two saponins, namely, azafrine1 (125) and azafrine2 (126), were reported from corms of saffron (Fig. 7.14; Mykhailenko et al. 2019).
7.5.1.14 Acetophenones and Anthraquinones
Acetophenones such as 2,3,4-trihydroxy-6-methoxyacetophenone-3-β-d-glucopyranoside (127) and 2,4-dihydroxy-6-methoxyacetophenone-2-β-d-glucopyranoside (128) and anthraquinones like emodin (129), 2-hydroxyemodin (130), 1-methyl-3-methoxy-8-hydroxyanthraquinone-2-carboxylic acid (131), and 1-methyl-3-methoxy-6,8-dihydroxyan- thraquinone-2-carboxylic acid (132) were isolated sprouts of C. sativus (Fig. 7.15; Gao et al. 1999a, b).
7.5.1.15 Others
γ-Lactone type of glucoside [3-(S)-3-β-d-glucopyranosyloxybutanolide] was isolated and characterized from sprouts of saffron (Gao et al. 1999a). Furthermore, macro- and micronutrients (Fe, Cu, Mn, Zn, Ca; Mykhailenko et al. 2019), amino acids, and saturated fatty acids were also detected in saffron (Table 7.1; Lim 2014; USDA 2013).
7.5.2 Pharmacological Activities
7.5.2.1 Antiparasitic and Antibacterial Activity
Several studies are reported on C. sativus for these activities. The isolated compounds from saffron (safranal and crocin) and semi-synthetic safranal derivatives were assessed against Helicobacter pylori for antibacterial and plasmodia and leishmania for antiparasitic potential, respectively (De Monte et al. 2015). The MIC50 of safranal against H. pylori was observed at 32.0 μg/mL, while its two synthetic derivatives (thiosemicarbazonic) at 4–8 μg/mL, exceeding the values of reference drugs metronidazole and clarithromycin (˃32 μg/mL). Hydrazothiazole was the most active compound (2–4 μg/mL). The synthetic derivatives showed lower activity against malaria, but high antileishmanial potential against L. infantum and L. tropica (IC50, 6–16 μg/mL) was observed when compared to amphotericin B antibiotic (IC50, 0.07–0.11 μg/mL). The highest antimalarial potential of crocin (IC50, 18.93 μg/mL) and safranal (IC50, 20 μg/mL) was found against the sensitive strain of chloroquine. Later, in vivo antimalarial activity of saffron stigmas was carried out against Plasmodium berghei. Chloroquine was used as a reference standard for accessing water and ethyl acetate extracts. The extracts moderately suppressed the parasitic count, but the combination of ethyl acetate fraction and chloroquine showed enhanced activity which further increases the survival percent of the mice as compared to treated with individual drug (Pestechian et al. 2015). Saffron leaves do not have any antimicrobial activity, while petals showed the activity against S. aureus, S. enteric, and S. dysenteriae (Jadouali et al. 2019).
7.5.2.2 Antioxidant Activity
Phenolics, crocetin, crocin, and safranal exhibited antioxidant activity in free radical scavenging assay (Hu et al. 2015). Saffron extract (300 μg/mL) showed 68.2% and 78.9% inhibition in the scavenging and reducing assays, respectively (Karimi et al. 2010). C. sativus leaves, petals, and flowers were also assessed for the concentration-dependent antioxidant potential, whereas petals showed highest while leaves were negligible in activities. Further, β-carotene oxidation inhibition and Cu2+-chelating capacity determined the antioxidant potential of leaves, tepals, and corms of saffron. The finding indicated that tepals and leaves reduced the oxidation of β-carotene, while corms were found as poor antioxidant with slight Cu2+chelating potential (Mykhailenko et al. 2019).
7.5.2.3 Hypotensive Activity
The hydro-alcoholic extract (200 mg/kg) of saffron stigmas were studied in normotensive and L-NAME-induced hypertensive rats (Nasiri et al. 2015), and it was observed that extract prohibited the rise in blood pressure and aortic reconstruction (*Р < 0.001). In another study, intravenous administration of safranal (1 mg/kg) and crocin (200 mg/kg) caused the reduction in the mean arterial blood pressure of the rats (60 ± 8.7, 50 ± 5.2, and 51 ± 3.8 mmHg, respectively) (Imenshahidi et al. 2010). Thus, both molecules of saffron showed excellent potential to treat hypertension.
7.5.2.4 Antidepressant Activity
Both stigmas and corms of the saffron have antidepressant potential that may be attributed due to the presence of crocin (Wang et al. 2010). Moreover, the saffron petals showed moderate activity at a dose of 30 mg/day (Moshiri et al. 2006).
7.5.2.5 Anxiolytic
Crocin was evaluated to assess its role to produce anxiolytic effects in light/dark model of rodents. The crocins (50 mg/kg) and diazepam (1.5 mg/kg) showed increase in latency time to enter the dark area and increased the time spent in the light compartment, while lower doses of crocins (15–30 mg/kg) did not modify the animal’s behaviour. These findings clearly indicated the anxiolytic potential of crocin (Pitsikas et al. 2008).
7.5.2.6 Anticonvulsant
The anticonvulsant potential of saffron (safranal and crocin) was investigated in pentylenetetrazol-induced epileptic model of rodents. The safranal at a dose of 0.15 and 0.35 ml/kg body weight, i.p., reduced the time interval of seizure, delayed onset of tonic seizures, and also protected the mice from death, while crocin (22 mg/kg, i.p.) did not show any antiepileptic activity (Hosseinzadeh and Talebzadeh 2005). But later, Tamaddonfard and his group reported that the crocin and diazepam combination has antiepileptic activities in rats at an effective dose of crocin (50 μg) with an ineffective dose of diazepam (2.5 μg). The study revealed that crocin potentiated the anticonvulsants of diazepam through GABAA-benzodiazepine receptor-mediated mechanism.
7.5.2.7 Memory-Enhancing and Anti-Alzheimer’s Activity
The saffron extract and its active constituents were evaluated to know the effect to prevent Alzheimer’s disease. The saffron extract (30 mg/day) showed better outcome on cognitive function than placebo after 16 weeks (Akhondzadeh et al. 2010a). In another study, it was observed that use of same dose for 6 months produced equivalent effect as that of donepezil (10 mg/day; Akhondzadeh et al. 2010b).
7.5.2.8 Antitumor Activity
Saffron and its chemical compounds have been evaluated for the therapeutic potential against the variety of cancers. The crocin-, picrocrocin-, and safranal-containing saffron stigma extracts reported to inhibit the growth of human tumor cells (Bhandari 2015; Escribano1996). Anti-proliferative activity on HCT-116, SW-480, and HT-29 (colorectal cancer) cell lines revealed that saffron and its major constituents restricted the proliferation of cancerous cells (Aung et al. 2007).
7.5.2.9 Cardiovascular Effect
Saffron and its bioactives exhibited cardioprotective characteristics in the evaluation of preclinical studies. Aqueous extract of C. sativus (20, 40, 80, and 160 mg/kg) and safranal (25, 50, 75 mL/kg) were reported to reduce the level of MDA content lipid peroxidation and level of MDA in the heart. CK-MB and LDH activities were reduced in serum of Wistar rats due to the effects of saffron and its bioactives (Mehdizadeh et al. 2013). Moreover, crocetin (50 mg/kg/day) prevents the inflammations and protects MIRI in rats by inhibiting ROS production. It has also shown reduction in myocardium apoptosis (Wang et al. 2014).
7.5.2.10 Antinociceptive and Anti-Inflammatory Activities
The petal and stigma of saffron have antinociceptive as well as anti-inflammatory potentials. These effects were might be due to the presence of bioactive agents of C. sativus (Hosseinzadeh and Younesi 2002).
7.5.2.11 Hypolipidemic and Hypoglycemic Activities
Crocin (100 mg), an important constituent of C. sativus, was found effective for patients with metabolic syndrome. The treatment for 1.5 months has shown reductions in the content of triglycerides and total cholesterols. This suggests the hypolipidemic potential of saffron. Further, the water extract of stigmas relieves cognition skills in the diabetic encephalopathy rats. It was observed that at a dose of 20, 40, and 80 mg/kg/day, the reduction in glucose levels was started at fourth, second, and first week of the extract administration, respectively (Kermani et al. 2017; Samarghandian et al. 2014).
7.5.2.12 Diuretic Activity
The diuretic activity of crocin and aqueous extract of saffron stigmas (60, 120, and 240 mg/kg) was reported by Shariatifar and workers (2014a, b). The results were calculated based on urine volume, electrolyte concentrations, creatinine, and urea. Thus, saffron extracts showed dose-dependent increment in the excretion of electrolytes, while crocin significantly increases the content of creatinine and urinary nitrites in urine of the rats (Hassanin 2015).
7.5.2.13 Cytotoxic Activity
In cytotoxic studies, saffron extracts (100, 200, 400, and 800 μg/mL) reduced the VEGF-A and VEGFR-2 gene expression in MCF-7 cell lines in comparison to control. The decline in VEGF-A (17%) and VEGFR-2 (20%) in gene expression at 800 and 400 μg/mL, respectively, was noted (Mousavi and Baharara 2014). Saffron extract and combination of crocin and safranal gave ІC50 values at 71 μg/mL and 39 μM for the antiproliferative activity against lymphoblastic T-cell leukaemia (Makhlouf et al. 2016). The saffron extract, crocin, and picrocrocin have shown cytotoxic and apoptogenic effects in malignant TC-1 and non-malignant COS-7 cell lines (Mykhailenko et al. 2019). The crocin (0.05–4 mM) and safranal (0.2–3.2 mM) showed significant cytotoxic effects against oral squamous cell carcinoma KB cells as well as NIH/3 T3 cells with the IC50 2.8 and 0.3 mM, respectively (Mykhailenko et al. 2019). The safranal also inhibited the proliferation of neuroblastoma cells with IC50 value of 11.1 and 23.3 μg/mL after 24 and 48 h, respectively. Moreover, the saffron corms bioactive combination (carbohydrates and protein) was found cytotoxic against human cervical epithelioid carcinoma cells (IC50, 7 mg/mL; Escribano et al. 1996, 2000). The triterpenoid saponins from corms were also active against HeLa tumoural cells (Mykhailenko et al. 2019).
7.5.2.14 Toxicity
C. sativus is considered safe even at a dose of more than1.5 g/day (Milajerdi et al. 2016). In animals, its lethal dose is 20.7 g/kg and no toxicity up to a dose of 5 g/kg was noticed. Isolated compounds crocin and dimethyl-crocetin were not found toxic in the Ames/Salmonella assay (Lari et al. 2015; Mykhailenko et al. 2019).
7.5.3 Standards and Criteria
7.5.3.1 Collection Period
The flowering of saffron remains only for 3–4 days and should be collected on the appearing of first flower. As the quality of flowers is affected by wind, sunlight, or heat, the best collection period is between October and November and should be done at dawn (Evans 1997; Kafi 2002).
7.5.3.2 Collection Method
Collection of flowers should be done by hand. Flowers have to be opened on the same day of collection. Opening of flowers before collection may lead to the destruction of stigmas and ultimately mixing with petals which will decrease the quality (Evans 1997; Hemmati Kakhki 2001).
7.5.3.3 Drying Methods
Stigmas must be dried for storage purposes. Quality and hence cost of saffron are mainly affected by drying process. Traditionally, stigmas were dried by putting them in baskets containing holes and hanging them on the roof at an appropriate temperature. Drying completes when the colour of stigmas changed to dark red. But this method was long and took around 10 days for drying. In the last few decades, the use of electric ovens is in trend. The recent method employed the use of a sterile silk net placed in the oven at 50–60 °C which gives high quality and fast drying (Dadkhah et al. 2003).
7.5.3.4 International Standards of Plant Material
The chemical characteristics of dried saffron as per ISO 3632-1 are depicted in Table 7.2. One of the main quality parameters is the measurement of colouring power through crocin, picrocrocin, and safranal) using ultraviolet-visible (UV-Vis) spectrophotometry. The colouring power of three quality categories for saffron threads at 440 nm should be 190, 150, and 100 units, respectively. In addition, the moisture content and maximum non-soluble ash content were also specified, and details are depicted in Table 7.2 (ISO/TS 2003).
7.5.3.5 Food and Drug Administration Criteria
Based on the FDA (Hemmati Kakhki 2001), the material must have the following properties:
-
Stigmas must be yellow and foreign matter should not be >10%.
-
The volatiles and humidity must not be >14% when the saffron dried at 100 °C.
-
The total ash not >1% while soluble ash should not >1%.
7.5.3.6 Adulterants
To reduce the cost of saffron, mixing is observed with beet, pomegranate, and red dyed silk fibres (Hagh-Nazari and Keifi 2007). In addition, the stamens of saffron are often adulterated with Carthamus tinctorius (safflower), Calendula officinalis (marigold), arnica, and tinted grasses to increase the product mass. Turmeric and paprika are combined with saffron powder. The labeling of Curcuma longa as “Indian saffron”, “American saffron”, or “Mexican saffron” also misleads the people. Besides, artificial colourants are another common way of adulteration (Kafi 2002).
7.5.3.7 Purity Check
Chemical Test
-
Saffron shouldn’t include yellow styles.
-
When pressed between filterpaper, it should not leave an oily stain.
-
When chewed, it should give a deep orange-yellow colour to the saliva.
-
When soaked in water, it should immediately dissolve and give a distinct yellow colour.
-
No colour is imparted to benzene when agitated with saffron.
-
Saffron extract gives a purple-blue colour when comes in contact with sulphuric acid.
7.5.3.8 Other Methods
Other methods include microscopic studies, colorimetric reactions, chromatographic techniques, TLC, and HPLC. HPLC is considered the most reliable technique (Hagh-Nazari and Keifi 2007). A colorimetric reflection method is based on CIE system where L* is brightness, a* redness-greenness, and b* yellowness-blueness, and correlated with the colouring power on samples (Alonso et al. 2003).Also, the atmospheric chemical ionization-mass spectrometry technique is a sensitive and easy method for quantitative analysis of volatile compounds (Taylor and Linforth 2003). Fourier transform near-infrared spectroscopy technique is also introduced for quality analysis of saffron that does not require any sample treatment (Zalacaín et al. 2003).
7.5.4 Commercialized Formulation
-
The topical polyherbal formulation (itch cream) for xerotic and pruritic skin disorders has been prepared with the ingredients (v/w basis): Curcuma longa (16.0%), C. sativus(0.025%), Santalum album (8.0%), vetiver (0.5%), A. moschatus (0.1%), Lawsonia inermis (3%), Ocimum sanctum (3%), and Glycyrrhiza glabra (0.5%) extracts, curcuma oil (6.1%), Surasar (0.5%), and Swarna Bhasma (0.00032%) in a non-greasy cream base q.s. (Chatterjee et al. 2005).
-
Scar removal skin cream (100 g) ingredients: wheat germ oil (3.5 mL), turmeric (20 g), neem (2 mL), sandal wood (1 mL), orange (2 g), rosemary oil (5 mL), A. vera gel (2 mL), saffron (1 g), cream base q.s. (Kalia 2005).
-
Tincture dose—5–20 min.
-
Saffron tea 1 in 80 (infusion).
7.5.5 Conclusion and Future Prospects
C. sativus is an important medicinal as well as food crop widely cultivated for nutritional and flavour purposes. In this book chapter, we tried to summarize the traditional claims, standardization methods, phytochemistry, pharmacological potential, and commercialized products of all parts of saffron. Besides, various physical parameters like temperature, humidity, wind, and methods that affect quality (flavour and colour) of saffron were also discussed. The main challenge is to meet the raw product demands that make it expensive in international market. Carotenoids, phenolics, and flavonoids are the main classes of secondary metabolites that are found in saffron. The main active constituents crocin, crocetin, and safranal are potential antitumor, anti-inflammatory, antiparasitic, and antibacterial agents. However, the effects have been slightly evaluated in humans. It would be interesting to see these effects in clinical trials.
Abbreviations
- CIE:
-
International Commission on Illumination
- FDA:
-
Food and Drug Administration
- HPLC:
-
High-performance liquid chromatography
- MDA:
-
Malondialdehyde
- TLC:
-
Thin layer chromatography
References
Abrishami MH (1997) Iranian saffron: historic, cultural and agronomic prospects. Astan Ghods Razavi Publication, Mashhad, pp 1–10
Akhondzadeh S et al (2010a) Saffron in the treatment of patients with mild to moderate Alzheimer’s disease: a 16-week, randomized and placebo-controlled trial. J Clin Pharm Ther 35:581–588
Akhondzadeh S et al (2010b) A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer’s disease. Psychopharmacology 207:637–643
Alonso GL et al (2003) Evaluation of the colour of Spanish saffron using tristimulus colorimetry. Italian J Food Sci 15:249–258
Aung HH et al (2007) Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells. Exp Oncol 29:175–180
Baba SA et al (2015a) Phytochemical analysis and antioxidant activity of different tissue types of Crocus sativus and oxidative stress alleviating potential of saffron extract in plants, bacteria, and yeast. South Afr J Bot 99:80–87
Baba SA et al (2015b) Comprehensive transcriptome analysis of Crocus sativus for discovery and expression of genes involved in apocarotenoid biosynthesis. BMC Genomics 16:698–729
Baumann BB (1960) The botanical aspects of ancient Egyptian embalming and burial. Econ Bot 14:84–104
Bhandari RP (2015) Crocus sativus L. (saffron) for cancer chemoprevention: a mini review. J Tradit Complement Med 5(2):8187
Carmona M et al (2007) Identification of the flavonoid fraction in saffron spice by LC/DAD/MS/MS: comparative study of samples from different geographical origins. Food Chem 100:445–450
Chatterjee S et al (2005) Emollient and anti-pruritic effect of itch cream in dermatological disorders: a randomized controlled trial. Indian J Pharmacol 37:253–254
Dadkhah MR, Ehtesham M, Fekrat H (2003) Iranian saffron an unknown jewel. Shahr Ashoob Publication, Tehran, pp 1–20
De Monte C et al (2015) Bioactive compounds of Crocus sativus L. and their semi-synthetic derivatives as promising anti-Helicobacter pylori, anti-malarial and anti-leishmanial agents. J Enzym Inhib Med Chem 30:1027–1033
Deo B (2003) Growing saffron—the world’s most expensive spice. Crop Food Res 20(1):1–4
Escribano J et al (1996) Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. Cancer Lett 100:23–30
Escribano J et al (2000) The cytolytic effect of a glycoconjugate extracted from corms of saffron plant (Crocus sativus) on human cell lines in culture. Planta Med 66:157–162
Esmaeili N et al (2011) Determination of some phenolic compounds in Crocus sativus L. corms and its antioxidant activities study. Pharmacogn Mag 7:74–80
Evans WC (1997) Trease and Evans’ pharmacognosy, 14th edn. WB Saunders Company Ltd., London, p 438
Feizy J, Reyhani N (2016) Gas chromatographic determination of phytosterols and fatty acids profile in saffron petals. Can Chem Trans 4:389–397
Gao WY, Li YM, Zhu DY (1999a) Phenolic glucosides and a γ-lactone glucoside from the sprouts of Crocus sativus. Planta Med 65:425–427
Gao WY, Li YM, Zhu DY (1999b) New anthraquinones from the sprout of Crocus sativus. Acta Bot Sin 41:531–533
García-Rodríguez MV et al (2017) Comparative evaluation of an ISO 3632 method and an HPLCDAD method for safranal quantity determination in saffron. Food Chem 221:838–843
Gismondi A et al (2012) Biochemical, antioxidant and antineoplastic properties of Italian saffron (Crocus sativus L.). Am J Plant Sci 3:1573–1580
Gregory MJ, Menary RC, Davies NW (2005) Effect of drying temperature and air flow on the production and retention of secondary metabolites in saffron. J Agric Food Chem 53:5969–5975
Grisolia S (1974) Hypoxia, saffron, and cardiovascular disease. Lancet 2:41–42
Grosso C (2016) Herbal medicine in depression: traditional medicine to innovative drug delivery. Springer International Publishing, New York, p 292
Hagh-Nazari S, Keifi N (2007) Saffron and various fraud manners in its production and trades. Acta Hortic (ISHS) 739:411–416
Harper D (2001) Online etymology dictionary. www.etymonline.com/index.php?search=saffron
Hashemi P, Erim FB (2016) Analysis of vitamin B2 in saffron stigmas (Crocus sativus L) by capillary electrophoresis coupled with laser-induced fluorescence detector. Food Anal Methods 9:2395–2399
Hassanin A (2015) Evaluation of the diuretic effects of crocin (active constituent of saffron) in rats. Int J Pharm Biol Sci 6:279–284
Hemmati Kakhki A (2001) Optimization of effective parameters on production of food color from saffron petals. Agr Sci Tech 15:13–20
Hosseinzadeh H, Talebzadeh F (2005) Anticonvulsant evaluation of safranal and crocin from Crocus sativus in mice. Fitoterapia 76:722–724
Hosseinzadeh H, Younesi H (2002) Petal and stigma extracts of Crocus sativus L. have antinociceptive and anti-inflammatory effects in mice. BMC Pharmacol 2:7
Hu J et al (2015) The influence of different drying methods on constituents and antioxidant activity of saffron from China. Int J Anal Chem 2015:1–8
Imenshahidi M, Hosseinzadeh H, Javadpour Y (2010) Hypotensive effect of aqueous saffron extract (Crocus sativus L.) and its constituents, safranal and crocin, in normotensive and hypertensive rats. Phytoter Res 24:990–994
ISO/TS-Technical Specification (2003) Crocus sativus L. Saffron. ISO, Switzerland, p 3236
Jadouali SM et al (2019) Chemical characterization and antioxidant compounds of flower parts of Moroccan Crocus sativus L. J Saudi Soc Agric Sci 18(4):476–480
Kafi M (2002) Saffron: production technology and manufacture. Ferdowsi University Publication, Mashhad
Kalia AN (2005) Textbook of industrial pharmacognosy. CBS Publishers and Distributors, New Delhi, p 270
Karimi E et al (2010) Evaluation of Crocus sativus L. stigma phenolic and flavonoid compounds and its antioxidant activity. Molecules 15:6244–6256
Kermani T et al (2017) The efficacy of crocin of saffron (Crocus sativus L.) on the components of metabolic syndrome: a randomized controlled clinical trial. J Res Pharm Pract 6:228–232
Kyriakoudi A et al (2012) Revisiting extraction of bioactive apocarotenoids from Crocus sativus L. dry stigmas (saffron). Anal Chim Acta 755:77–85
Lage M et al (2015) Phytochemical composition of Moroccan saffron accessions by headspace solidphase-microextraction. Am J Essential Oils Nat Prod 2:1–7
Lari P et al (2015) Evaluation of diazinon-induced hepatotoxicity and protective effects of crocin. Toxicol Ind Health 31:367–376
Li CY, Lee EJ, Wu TS (2004) Antityrosinase principles and constituents of the petals of Crocus sativus. J Nat Prod 67:437–440
Li CY, Wu TS (2002a) Constituents of the stigmas of Crocus sativus and their tyrosinase inhibitory activity. J Nat Prod 65:1452–1456
Li CY, Wu TS (2002b) Constituents of the pollen of Crocus sativus L. and their tyrosinase inhibitory activity. Chem Pharm Bull 50:1305–1309
Lim TK (2014) Edible medicinal and non-medicinal plants flowers. Crocus sativus, vol 8. Springer, Netherlands, pp 77–136
Liorens S et al (2015) Effects of crocetin esters and crocetin from Crocus sativus L. on aortic contractility in rat genetic hypertension. Molecules 20:17570–17584
Lotfi L et al (2015) Effects of enzymatic extraction on anthocyanins yield of saffron tepals (Crocus sativus) along with its color properties and structural stability. J. Food Drug Anal 23:210–218
Maggi L et al (2010) Changes in saffron volatile profile according to its storage time. Food Res Int 43:1329–1334
Makhlouf H et al (2016) In vitro antiproliferative activity of saffron extracts against human acute lymphoblastic T-cell human leukemia. Indian J Trad Knowl 15:16–21
Malairajan PG et al (2006) Analgesic activity of some Indian medicinal plants. J Ethnopharmacol 106(3):425–428
Mehdizadeh R et al (2013) Cardioprotective effect of saffron extract and safranal in isoproterenol-induced myocardial infarction in Wistar rats. Iran J Basic Med Sci 16(1):56–63
Milajerdi A, Djafarian K, Hosseini B (2016) The toxicity of saffron (Crocus sativus L.) and its constituents against normal and cancer cells. J Nutr Interm Metab 3:23–32
Montoro P et al (2008) Qualitative profile and quantitative determination of flavonoids from Crocus sativus L. petals by LC-MS/MS. Nat Prod Commun 3:2013–2016
Montoro P et al (2012) Radical scavenging activity and LC-MS metabolic profiling of petals, stamens, and flowers of Crocus sativus L. J. Food Sci 77:893–900
Moraga ÁR et al (2009a) Cloning and characterization of a glucosyltransferase from Crocus sativus stigmas involved in flavonoid glucosylation. BMC Plant Biol 9:109
Moraga AR et al (2009b) Metabolite and target transcript analyses during Crocus sativus stigma development. Phytochemistry 70:1009–1016
Moshiri E et al (2006) Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. Phytomedicine 13: 607-611
Mousavi M, Baharara J (2014) Effect of Crocus sativus L. on expression of VEGF-A and VEGFR-2 genes (angiogenic biomarkers) in MCF-7 cell line. Zahedan J Res Med Sci 16:8–14
Mozaffarian V (1996) A dictionary of Iranian plant names. Farhang Moaser Publisher, Tehran, p 165
Mykhailenko O et al (2019) Biologically active compounds and pharmacological activities of species of the genus Crocus: a review. Phytochemistry 162:56–89
Nasiri Z et al (2015) Dietary saffron reduced the blood pressure and prevented remodeling of the aorta in L-NAME-induced hypertensive rats. Iran J Basic Med Sci 18:1143–1146
Norbeak R et al (2002) Flower pigment composition of Crocus species and cultivars used for a chemotaxonomic investigation. Biochem Syst Ecol 30:763–791
Ordoudi SA, Tsimidou MZ (2004) Saffron quality: effect of agricultural practices, processing and storage: production practices and quality assessment of food crops, vol 1. Springer, Dordrecht
Pestechian N et al (2015) Effect of Crocus sativus stigma (saffron) alone or in combination with chloroquine on chloroquine sensitive strain of plasmodium berghei in mice. J Herb Med Pharmacol 4:110–114
Pfander H, Schurtenberger H (1982) Biosynthesis of C20-carotenoids in Crocus sativus L. Phytochemistry 21:1039–1042
Pitsikas N et al (2008) Effects of the active constituents of Crocus sativus L. in an animal model of anxiety. Phytomedicine 15:1135–1139
Rubio-Moraga Á et al (2011) Triterpenoid saponins from corms of Crocus sativus: localization, extraction and characterization. Ind Crop Prod 34:1401–1409
Saeidnia S (2012) Future position of Crocus sativus as a valuable medicinal herb in phytotherapy. Pharmacogn J 4(27):71
Samarghandian S, Azimi-Nezhad M, Samini F (2014) Ameliorative effect of saffron aqueous extract on hyperglycemia, hyperlipidemia, and oxidative stress on diabetic encephalopathy in streptozotocin induced experimental diabetes mellitus. BioMed Res Int 2014:920857
Sánchez-Vioque R et al (2016) Polyphenol composition and in vitro antiproliferative effect of corm, tepal and leaf from Crocus sativus L. on human colon adenocarcinoma cells (Caco-2). J Funct Foods 24:18–25
Schmidt M, Betti G, Hensel A (2007) Saffron in phytotherapy: pharmacology and clinical uses. Wien Med Wochenschr 157:315–319
Shariatifar N et al (2014a) Study on diuretic activity of saffron (stigma of Crocus sativus L.) aqueous extract in rat. J Adv Pharm Technol Res 5:17–20
Shariatifar N et al (2014b) Study on diuretic activity of saffron (stigma of Crocus sativus L.) aqueous extract in rat. J Adv Pharm Technol Res 5:17–20
Srivastavan R et al (2010) Crocus sativus L.: a comprehensive review. Pharmacogn Rev 4(8): 200-208
Straubinger M et al (1997) Two kaempferol sophorosides from Crocus sativus. Nat Prod Lett 10:213–216
Tarantilis PA, Polissiou MG (1997) Isolation and identification of the aroma components from saffron (Crocus sativus). J Agric Food Chem 45:459–462
Taylor AJ, Linforth RS (2003) Direct mass spectrometry of complex volatile and non-volatile flavour mixtures. Int J Mass Spectrom 223:179–191
Termentzi A, Kokkalou E (2008) LC-DAD-MS (ESI+) analysis and antioxidant capacity of Crocus sativus petal extracts. Planta Med 74:573–581
Tung NH, Shoyama Y (2013) New minor glycoside components from saffron. J Nat Med 67:672–676
U.S. Department of Agriculture, Agricultural Research Service (USDA) (2013) USDA national nutrient database for standard reference, release 26. Nutrient Data
USDA N (2009) The PLANTS database. http://plants.usda.gov/java/
Vignolini P et al (2008) Characterization of by-products of saffron (Crocus sativus L.) production. Nat Prod Commun 3:1959–1962
Wang Y et al (2010) Antidepressant properties of bioactive fractions from the extract of Crocus sativus L. J Nat Med 64:24–30
Wang Y et al (2014) Protective effects of crocetin pretreatment on myocardial injury in an ischemia/reperfusion rat model. Eur J Pharmacol 741:290–296
Wani BA, Hamza AKR, Mohiddin FA (2011) Saffron: a repository of medicinal properties. J Med Plant Res 5(11):2131–2135
Zalacaín A et al (2003) FT-NIR spectrometry approach for determining saffron origin. Acta Hortic 650:22–25
Zhou J, Xie G, Yan X (2011) Encyclopedia of traditional Chinese medicines: molecular structures, pharmacological activities, natural sources and applications. Isolated compounds a-C. Springer-Verlag, Berlin, p 3934
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Sharma, S., Kumar, D. (2022). Chemical Composition and Biological Uses of Crocus sativus L. (Saffron). In: Masoodi, M.H., Rehman, M.U. (eds) Edible Plants in Health and Diseases . Springer, Singapore. https://doi.org/10.1007/978-981-16-4959-2_7
Download citation
DOI: https://doi.org/10.1007/978-981-16-4959-2_7
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-4958-5
Online ISBN: 978-981-16-4959-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)